Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hepatitis A and E

Gastroenterology and hepatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Confusion, asterixis, hypoglycaemia, rising INR, bleeding, severe vomiting, haemodynamic instability or rapidly deepening jaundice during acute hepatitis suggests acute liver failure or another major complication. Admit, stop non-essential hepatotoxic medicines, monitor glucose and coagulation closely, and discuss early with a regional liver-transplant centre rather than waiting for established coma. Pregnant patients with suspected hepatitis E and immunosuppressed people with persistent HEV require especially prompt specialist input.

Synopsis

Recognise enterically transmitted viral hepatitis, diagnose hepatitis A and E accurately, identify acute liver failure, and apply UK prevention and public-health measures.

  • Hepatitis A spreads mainly by the faeco-oral route and does not become chronic, although cholestatic or relapsing illness can prolong recovery.
  • Hepatitis E in the UK is often zoonotic and linked to undercooked pork or game; absence of foreign travel does not exclude it.
  • Test for HAV IgM in compatible acute illness and request HEV serology with RNA testing according to timing and immune status.
  • An isolated positive total HAV antibody usually indicates past infection or vaccination and does not diagnose current acute hepatitis.
  • Most immunocompetent patients receive supportive care, avoidance of alcohol and careful review of prescribed and non-prescribed hepatotoxic exposure.
  • HEV can persist after solid-organ transplantation or other immunosuppression; chronicity requires viral RNA follow-up and specialist management.
  • Acute infectious hepatitis is notifiable in the UK jurisdictional framework; contact the local health-protection team for case and contact measures.
  • HAV vaccination and post-exposure prophylaxis follow current Green Book and UKHSA risk assessment; there is no routinely available UK HEV vaccine.

Key red flags

Acute liver failure

Encephalopathy with coagulopathy in a person without established cirrhosis is a transplant emergency, even before bilirubin becomes extreme or a viral result returns.

Pregnancy and HEV

Acute jaundice after travel or relevant exposure during pregnancy requires immediate obstetric and liver assessment because severe HEV-associated liver failure is possible.

Investigation priorities

01
Liver profile and coagulationFirst step

Confirm hepatocellular injury, assess cholestasis and detect failing synthetic function.

Management branches

DiagnoseInvestigate acute jaundice

A patient has a hepatitic liver profile, dark urine, jaundice or a compatible exposure history.

  1. Assess physiological stability, cognition, glucose, INR and medication or toxin exposure before awaiting pathogen tests, and arrange emergency liver-centre discussion if failure features appear.
  2. Request HAV IgM and HEV testing alongside a broader cause-directed acute-hepatitis screen, explicitly telling the laboratory about immunosuppression, pregnancy, onset and relevant food or travel exposures.
  3. Use ultrasound when obstruction or another structural cause is possible, then interpret serology and RNA with timing rather than accepting any isolated antibody result uncritically.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UKHSA hepatitis A Green Book chapterCurrent UK vaccination, risk-group and post-exposure prophylaxis framework for hepatitis A.
  • UKHSA hepatitis A prevention and control guidanceNational case, contact, exclusion, outbreak and public-health management guidance.
  • UKHSA hepatitis E guidance collectionOfficial UK resources covering HEV diagnosis, management, epidemiology and surveillance.
  • UKHSA hepatitis E clinical informationUK transmission, food risk, diagnostic testing, clinical course and prevention advice.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom